Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD
Status:
Completed
Trial end date:
2021-12-21
Target enrollment:
Participant gender:
Summary
The changes in liver function, body mass index, controlled attenuation parameters, liver
stiffness and HBV-DNA at different time points in each group before and after treatment were
counted to explore the clinical efficacy of Ganshuang granules combined with tenofovir in the
treatment of CHB complicated with NAFLD.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sichuan Leshan Traditional Chinese Medicine Hospital